Cleared Traditional

K121184 - SENSUS

K121184 is an FDA 510(k) clearance for SENSUS, manufactured by Neurometrix, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 106-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
106d
Days
Class 2
Risk

K121184 is an FDA 510(k) clearance for the SENSUS. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Neurometrix, Inc. (Waltham, US). The FDA issued a Cleared decision on August 2, 2012 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K121184

510(k) Number K121184 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 18, 2012
Decision Date August 02, 2012
Days to Decision 106 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d faster than avg
Panel avg: 149d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 380
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K121184.
NEURODYN RUBY MUSCLE STIMULATOR, NEURODYN AUSSIE MUSCLE STIMULATOR
K121369 · Ibramed Equipamentos Medicos · Dec 2012
STERLING MEDICAL IMPULSE 3 STIMULATOR
K121305 · Armstrong Industries, Inc. Dha Mediquip Int. Dha S · Sep 2012
WITOUCH PRO
K120398 · Hollywog, LLC · Aug 2012
ATOM 1 (MODEL: BRC 2200)
K121578 · Bioelectric Research Corporation · Jul 2012
ELECTRONIC PULSE MASSAGER TENS ELECTRONIC PULSE MASSAGER
K113544 · Prospera Corporation · Jul 2012
GEMORE TENS SYSTEM
K120569 · Gemore Technology Co, Ltd. · Jul 2012